Conference item icon

Conference item

Genomic surveillance and meningococcal group B vaccine coverage estimates after introduction of the vaccine into the national immunisation programme in the UK

Abstract:
In September, 2015, the meningococcal group B vaccine (Bexsero, GlaxoSmithKline) was introduced into the UK childhood immunisation schedule. Prelicensure coverage estimates used Meningococcal Antigen Typing System (MATS) to determine phenotype and function of circulating meningococci. Using whole-genome sequencing, we aimed to perform rapid, scalable, high-resolution
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1016/S0140-6736(17)30481-6

Authors


More by this author
Institution:
University of Oxford
Division:
MPLS
Department:
Zoology
Role:
Author
Wellcome Trust More from this funder
Publisher:
Elsevier Publisher's website
Host title:
Spring Meeting for Clinician Scientists in Training 2017
Journal:
Spring Meeting for Clinician Scientists in Training 2017 Journal website
Publication date:
2017-02-01
Acceptance date:
2016-12-05
DOI:
EISSN:
1474-547X
ISSN:
0140-6736
Source identifiers:
718520
Pubs id:
pubs:718520
UUID:
uuid:0dfa813b-defd-4595-9f16-c938613e3cb6
Local pid:
pubs:718520
Deposit date:
2017-12-18

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP